Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences